BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11487383)

  • 21. Total platelet donation count and donation frequency are determinants of plateletpheresis-associated lymphopenia.
    Thuer L; Brosig A; Hutchinson JA; Hähnel V; Offner R; Burkhardt R; Ahrens N
    Transfusion; 2021 Nov; 61(11):3161-3173. PubMed ID: 34545947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementation of concurrent red blood cell and platelet collection by apheresis in a university haemapheresis unit.
    Moog R
    Transfus Med; 2004 Apr; 14(2):145-50. PubMed ID: 15113378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A flow cytometric method for detection and enumeration of low-level, residual red blood cells in platelets and mononuclear cell products.
    Santana JM; Dumont LJ
    Transfusion; 2006 Jun; 46(6):966-72. PubMed ID: 16734813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and storage of white blood cell-reduced split apheresis platelet concentrates for pediatric use.
    van der Meer PF; Vrielink H; Pietersz RN
    Transfusion; 2005 Feb; 45(2):223-7. PubMed ID: 15660831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent platelet donation is associated with lymphopenia and risk of infections: A nationwide cohort study.
    Zhao J; Gabriel E; Norda R; Höglund P; Baden L; Diedrich BA; Marits P; Enoksson SL; Gansner JM; Kaufman R; Dickman PW; Edgren G
    Transfusion; 2021 Feb; 61(2):464-473. PubMed ID: 33186486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The selection of donors in multicomponent collection management.
    Bonomo P; Garozzo G; Bennardello F
    Transfus Apher Sci; 2004 Feb; 30(1):55-9. PubMed ID: 14746822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 3-year analysis of plateletpheresis donor deferral pattern in a tertiary health care institute: assessing the current donor selection criteria in Indian scenario.
    Tondon R; Pandey P; Chaudhry R
    J Clin Apher; 2008; 23(4):123-8. PubMed ID: 18615635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Leukodepletion of labile blood products].
    Vignon D
    Ann Pharm Fr; 1999 Jan; 57(1):61-7. PubMed ID: 10073051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors influencing yield of plateletpheresis using intermittent flow cell separator.
    DAS SS; Chaudhary RK; Shukla JS
    Clin Lab Haematol; 2005 Oct; 27(5):316-9. PubMed ID: 16178912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapeutic thrombocytapheresis in patients with myeloproliferative diseases with the cell separators Fresenius AS 104 and Cobe Spectra: biocompatibility and safety].
    Ullrich H; Kadar J; Waxenberger Y; Hohe R; Saueressig C; Heyder M; Wiebecke D
    Beitr Infusionsther; 1992; 30():311-4. PubMed ID: 1284723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation of highly concentrated and white cell-poor platelet-rich plasma by plateletpheresis.
    Zimmermann R; Reske S; Metzler P; Schlegel A; Ringwald J; Eckstein R
    Vox Sang; 2008 Jul; 95(1):20-5. PubMed ID: 18444946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Events at blood collection area due to nonconforming blood bags and plateletpheresis kits: need for timely corrective and preventive actions.
    Verma A; Sachan D; Elhence P; Pandey H; Dubey A
    Transfusion; 2012 Jul; 52(7 Pt 2):1622-7. PubMed ID: 22780944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leucodepletion for hyperleucocytosis--first report on a novel technology featuring electronic interphase management.
    Schulz M; Bug G; Bialleck H; Serve H; Seifried E; Bönig H
    Vox Sang; 2013 Jul; 105(1):47-53. PubMed ID: 23384315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rates of vaso-vagal reactions among first time teenaged whole blood, double red cell, and plateletpheresis donors.
    Reiss RF; Harkin R; Lessig M; Mascari J
    Ann Clin Lab Sci; 2009; 39(2):138-43. PubMed ID: 19429799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Further results with the COBE Spectra system. Platelet collection using the COBE Spectra.
    Price TH; Northway MM; Moore RC
    Infusionstherapie; 1989 Aug; 16 Suppl 2():44. PubMed ID: 2583844
    [No Abstract]   [Full Text] [Related]  

  • 36. Flow cytometric analysis of lymphocyte contamination of plateletpheresis products.
    Müller N; Ostendorf N; Schmitz G
    Beitr Infusionsther; 1991; 28():223-5. PubMed ID: 1725626
    [No Abstract]   [Full Text] [Related]  

  • 37. Plateletpheresis with the COBE spectra single needle access option.
    McLeod BC; McKenna R; Viernes A; Reed S; Owens EA; Matayoshi D; Moore RC
    J Clin Apher; 1991; 6(1):24-7. PubMed ID: 2045379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study of automated plateletpheresis using five different apheresis systems in a tertiary care hospital.
    Chaudhary R; Das SS; Khetan D; Ojha S; Verma S
    Transfus Apher Sci; 2009 Apr; 40(2):99-103. PubMed ID: 19237317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leukoreduced platelet apheresis production with a modified COBE spectra collection protocol.
    Kuriyan M; Opalka A
    J Clin Apher; 1995; 10(2):85-6. PubMed ID: 7592522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.